Dual-antigen targeted iPSC-derived chimeric antigen receptor-T cell therapy for refractory lymphoma

Sakiko Harada(Juntendo University), Norio Komatsu(Juntendo University), Mahito Nakanishi(Tokiwa University), Manami Ohtaka(National Institute of Advanced Industrial Science and Technology), Yozo Nakazawa(Tokyo University of Agriculture), Tokuko Toyota(Juntendo University), Kazutaka Nakashima(Kurume University), Midori Ishii(Juntendo University), Koichi Ohshima(Kurume University), Satoshi Yamazaki(Institute for Stem Cell Biology and Regenerative Medicine), Hiromitsu Nakauchi(University of Tsukuba), Chansu Shin(Niigata University), Chihaya Imai(University of Toyama), Yasunori Ota(Tokyo University of Science), Tomoyuki Yamaguchi(The University of Tokyo), Kazuo Ohara(Juntendo University), Miki Ando(Juntendo University), Jun Ando(Juntendo University)
Molecular Therapy
October 9, 2021
Cited by 48


Related Papers